| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.094 | 0.07 |